Instil Bio Inc. (TIL) NASDAQ
$10.71 (0.04) (-0.37%)
Market Cap: $69.66M
As of 04/24/24 04:00 PM EDT. Market closed.
Instil Bio Inc. (TIL)
NASDAQ
$10.71
(0.04) (-0.37%)
Market Cap: $69.66M
As of 04/24/24 04:00 PM EDT. Market closed.
Add to Portfolio
instil bio is a cell therapy company developing tumor infiltrating lymphocytes (til) for the treatment of solid tumor cancers. til are a patient’s own t cells harvested from the patient’s tumor, which are then expanded and reinfused into the patient to target and kill cancer cells. the company is advancing its proprietary manufacturing expertise, technology, and data into clinical trials, ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Bronson Crouch
Full Time Employees
335
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Bronson Crouch
Full Time Employees
335
Address
3963 Maple Avenue, Suite 350, TX, Dallas, 75219.
PRICE CHART FOR INSTIL BIO INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$10.56
Previous Close
$10.75
Days Range
$10.45 - $10.71
52 week range
$6.07 - $14
Volume
5,112
Avg. Volume (30 days)
9,971
Market Cap
$69.66M
Dividend Yield
-
P/E
-
Shares Outstanding
6,503,913
Open
$10.56
Previous Close
$10.75
Days Range
$10.45 - $10.71
52 week range
$6.07 - $14
Volume
5,112
Avg. Volume (30 days)
9,971
Market Cap
$69.66M
Dividend Yield
-
P/E
-
Shares Outstanding
6,503,913
FINANCIAL STATEMENTS FOR INSTIL BIO INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR INSTIL BIO INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Vivo Capital IX, LLC | 10% Owner | Mar 23, 2021 | Buy | $20.00 | 300,000 | 6,000,000 | 12,486,787 | Mar 25, 2021, 05:32 PM |
| Shah Nimish P | Director | Mar 23, 2021 | Buy | $20.00 | 300,000 | 6,000,000 | 5,635,937 | Mar 25, 2021, 05:31 PM |
| Nielsen Jack | Director | Mar 23, 2021 | Buy | $20.00 | 300,000 | 6,000,000 | 12,486,787 | Mar 25, 2021, 05:30 PM |
| McGaughy R Kent Jr | Director | Mar 23, 2021 | Buy | $20.00 | 450,000 | 9,000,000 | 8,478,790 | Mar 25, 2021, 05:28 PM |
| Curative Ventures V LLC | 10% Owner | Mar 23, 2021 | Buy | $20.00 | 450,000 | 9,000,000 | 37,980,073 | Mar 25, 2021, 04:29 PM |
| Crouch Bronson | CEO and Chairman | Mar 23, 2021 | Buy | $20.00 | 450,000 | 9,000,000 | 37,980,073 | Mar 25, 2021, 04:27 PM |
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Vivo Capital IX, LLC | 10% Owner | 03/23/2021 | 6,000,000 |
| Shah Nimish P | Director | 03/23/2021 | 6,000,000 |
| Nielsen Jack | Director | 03/23/2021 | 6,000,000 |
| McGaughy R Kent Jr | Director | 03/23/2021 | 9,000,000 |
| Curative Ventures V LLC | 10% Owner | 03/23/2021 | 9,000,000 |
| Crouch Bronson | CEO and Chairman | 03/23/2021 | 9,000,000 |
FUNDS WITH A POSITION IN INSTIL BIO INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| VIVO CAPITAL, LLC | 624,338 | 0.53% | -0.00032% | Other |
| RENAISSANCE TECHNOLOGIES LLC | 113,614 | 0.00134% | New | Other |
| BLACKROCK INC. | 37,600 | 0.00001% | New | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 31,426 | 0.00003% | New | Other |
CHANGE IN SHARES OUTSTANDING FOR INSTIL BIO INC
STOCK BUYBACKS FOR INSTIL BIO INC
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
03/31/2021
-81.41%
11Q
12/31/2020
-62.06%
12Q
09/30/2020
-61.58%
13Q
06/30/2020
-61.39%
14Q
03/31/2020
-49.96%
15Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR INSTIL BIO INC
LOADING...